GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 785 filers reported holding GLAXOSMITHKLINE PLC in Q1 2018. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $19,000 | -24.0% | 445 | -33.1% | 0.01% | 0.0% |
| Q3 2021 | $25,000 | -3.8% | 665 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $26,000 | +8.3% | 665 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $24,000 | 0.0% | 665 | 0.0% | 0.01% | -10.0% |
| Q4 2020 | $24,000 | +9.1% | 665 | +12.5% | 0.01% | -9.1% |
| Q3 2020 | $22,000 | -8.3% | 591 | 0.0% | 0.01% | -15.4% |
| Q2 2020 | $24,000 | +4.3% | 591 | 0.0% | 0.01% | -55.2% |
| Q1 2020 | $23,000 | -28.1% | 591 | -21.8% | 0.03% | +38.1% |
| Q3 2019 | $32,000 | +3.2% | 756 | 0.0% | 0.02% | 0.0% |
| Q2 2019 | $31,000 | 0.0% | 756 | 0.0% | 0.02% | -4.5% |
| Q1 2019 | $31,000 | +6.9% | 756 | 0.0% | 0.02% | -4.3% |
| Q4 2018 | $29,000 | -6.5% | 756 | 0.0% | 0.02% | +9.5% |
| Q3 2018 | $31,000 | +19.2% | 756 | +17.0% | 0.02% | +10.5% |
| Q2 2018 | $26,000 | -60.0% | 646 | -61.2% | 0.02% | -60.4% |
| Q1 2018 | $65,000 | – | 1,665 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $17,248,000 | 7.33% |
| KAHN BROTHERS GROUP INC | 1,055,085 | $45,495,265,000 | 6.94% |
| NEXTHERA CAPITAL LP | 322,000 | $13,885,000 | 6.05% |
| EQUITY INVESTMENT CORP | 2,494,668 | $107,570,000 | 3.68% |
| Bruderman Asset Management, LLC | 310,248 | $13,378,000 | 3.57% |
| Keystone Financial Planning, Inc. | 131,006 | $5,649,000 | 3.42% |
| SPHERA FUNDS MANAGEMENT LTD. | 450,000 | $19,404,000 | 3.30% |
| Hamlin Capital Management, LLC | 1,765,115 | $76,112,000 | 3.18% |
| Holloway Wealth Management, LLC | 116,899 | $5,041,000 | 3.16% |
| P.R. Herzig & Co. Inc. | 37,650 | $1,623,000 | 3.14% |